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Abstract
Human African Trypanosomiasis (HAT) or sleeping sickness is a Neglected Tropical Dis-
ease. Long regarded as an invariably fatal disease, there is increasing evidence that infec-
tion by T. b. gambiense can result in a wide range of clinical outcomes, including latent
infections, which are long lasting infections with no parasites detectable by microscopy. The
determinants of this clinical diversity are not well understood but could be due in part to para-
site or host genetic diversity in multiple genes, or their interactions. A candidate gene associ-
ation study was conducted in Coˆte d’Ivoire using a case-control design which included a
total of 233 subjects (100 active HAT cases, 100 controls and 33 latent infections). All three
possible pairwise comparisons between the three phenotypes were tested using 96 SNPs
in16 candidate genes (IL1, IL4, IL4R, IL6, IL8, IL10, IL12, IL12R, TNFA, INFG, MIF, APOL1,
HPR, CFH, HLA-A and HLA-G). Data from 77 SNPs passed quality control. There were sug-
gestive associations at three loci in IL6 and TNFA in the comparison between active cases
and controls, one SNP in each of APOL1, MIF and IL6 in the comparison between latent
infections and active cases and seven SNP in IL4, HLA-G and TNFA between latent infec-
tions and controls. No associations remained significant after Bonferroni correction, but the
Benjamini Hochberg false discovery rate test indicated that there were strong probabilities
that at least some of the associations were genuine. The excess of associations with latent
infections despite the small number of samples available suggests that these subjects form
a distinct genetic cluster different from active HAT cases and controls, although no cluster-
ing by phenotype was observed by principle component analysis. This underlines the
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Author summary
Since it was first identified, human African trypanosomiasis (HAT) or sleeping sickness
has been described as invariably fatal. Recent data however suggest that infection by T. b.
gambiense can result in a wide range of clinical outcomes in its human host including long
lasting infections, that can be detected by the presence of antibodies, but in which para-
sites cannot be seen by microscopy; these cases are known as latent infections. While the
factors determining, this varied response have not been clearly characterized, the effectors
of the immune responses have been partially implicated as key players. We collected sam-
ples from people with active HAT, latent infections and controls in endemic foci in the
Coˆte d’Ivoire. We tested the role of single nucleotide polymorphisms (SNPs) in 16 genes
on susceptibility/resistance to HAT by means of a candidate gene association study. There
was some evidence that variants of the genes for IL4, IL6, APOL1, HLAG, MIF and TNFA
modified the risk of developing HAT. These proteins regulate the inflammatory response
to many infections or are directly involved in killing the parasites. In this study, the results
were statistically weak and would be inconclusive on their own, however other studies
have also found associations in these genes, increasing the chance that the variants that we
have identified play a genuine role in the response to trypanosome infection in Coˆte
D’Ivoire.
Introduction
Sleeping sickness, or human African Trypanosomiasis (HAT), is caused by Trypanosoma bru-
cei gambiense and T.b. rhodesiense and is transmitted by tsetse flies (Glossina spp). T. b. gam-
biense is associated with a more chronic disease that can take decades to become patent, and T.
b. rhodesiense causes an acute disease within months of infection. The chronic form of the dis-
ease caused by the T. b. gambiense is classically characterized by an early hemolymphatic stage
(stage 1) associated with non-specific symptoms such as intermittent fevers and headaches, fol-
lowed by a meningo-encephalitic stage (stage 2) in which the parasite invades the central ner-
vous system and causes neurological disorders and death if left untreated. This chronic form is
found in Western and Central Africa while the acute form caused by T. b. rhodesiense is
endemic to Eastern Africa [1,2]. However, recent observations are increasingly indicating that
infection by T. b. gambiense can result in a wide range of clinical outcomes in its human host
[3,4]. Self-cure processes have been described and reviewed in Checchi et al. [3]. Furthermore,
some authors argued that HAT is not invariably fatal [5], supporting observations made by
Garcia et al. [4] who followed individuals who remained seropositive for HAT but without
detectable parasites for two years. This clinical diversity is not well understood but could be
due to parasite genetic diversity [6,7], human immune gene variability [8] or their interaction
[9]. It has been suggested that genetic polymorphisms of the parasite could be associated with
asymptomatic and very chronic infections [10]. Nevertheless, genes involved in the host
immune response have been implicated in the control of infection or susceptibility to HAT
[11,12] and also T. congolense infections in experimental models [13,14]. Among the genes
implicated in the pathogenesis of the disease, are interleukins 1, 4, 6, 8, 10 and 12 (IL1, IL4,
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IL6, IL8, IL10 and IL12), tumor necrosis factor A (TNFA), interferon G (INFG), complement
factor H (CFH), macrophage inhibitory factor (MIF), [8,11,15–17].
Some studies have found associations between certain polymorphisms in genes encoding
cytokines. For example, IL4 plays a role in susceptibility to T. brucei infection [18], while poly-
morphisms in the IL6 and IL10 genes have been associated with a decreased risk of developing
HAT [11,15]. On the other hand, polymorphisms in TNFA genes have been associated with an
increased risk of developing the disease [11,15]. Furthermore, MacLean et al. [19] reported in
their study that plasma levels of IFNG significantly decrease during the late stage of the T.b.
rhodesiense disease [19]. Human blood contains trypanolytic factors 1 and 2 (TLF1 and TLF2)
that are lytic to almost all African trypanosomes except T. b. rhodesiense and T. b. gambiense
[20]. Human TLF1 contains two primate-specific proteins, apolipoprotein L1 (APOL1) and
haptoglobin-related protein (HPR). APOL1 expression is induced by T. b. gambiense infection
but expression is not associated with susceptibility to sleeping sickness [21]. MIF contributes
to inflammation-associated pathology in the chronic phase of T. brucei infection [16].
Although genes directly involved in the immune response, like genes encoding cytokines,
are very important candidates, genes implicated in the regulation of immunity also have a crit-
ical role. Thus, Courtin et al. [12] have shown a genetic association between human leukocyte
antigen G (HLA-G) polymorphisms and susceptibility to HAT.
There is now cumulative evidence that polymorphisms in genes involved in the control of
the immune response and genes implicated in the regulation of immunity could play a role in
HAT infection outcome [11,12].
We report a candidate gene association study of the role of single nucleotide polymor-
phisms (SNP) in IL1, IL4, IL6, IL8, IL10, IL12, interleukin 4 receptor (IL4R), interleukin 12
receptor (IL12R), TNF, INFG, MIF, haptoglobin-related protein (HPR), CFH, APOL1, HLA-A
and HLA-G genes on susceptibility/resistance to HAT.
Results
Characteristics of the population
A total of 100 cases, 100 controls and 33 latent infections were enrolled into the study
(Table 1). The mean age (range) of the study population was 38.8 (6–84) years. The sex ratio
(male: female) was 0.88 (109/124).
Association study
Three association analyses were run on the three possible pairwise combinations of the con-
trols, latent infections and active HAT cases. After filtering out SNP loci that were not in
Hardy Weinberg equilibrium (HWE) (P<0.001), or had > 10% missing genotypes or had
minor allele frequencies of zero, 77 SNP loci remained in the latent infection vs active case
comparison and 74 SNP loci remained in the other two comparisons. One individual was fil-
tered out of the case sample and one out of the latent infection sample because of low genotyp-
ing rates (<90%).
FST between ethnic groups showed that allele frequency differences between the ethnic
groups were small, indicating that ethnicity was unlikely to confound results (median Fst
-0.00011763, Fst maximum 0.015). Scatter plots of the first two principal components between
the different phenotypes (cases, latent infections and controls) and different ethnic groups
show that this population is homogeneous and that the samples did not cluster by phenotype
or by ethnic groups (Fig 1) and consequently the data were not stratified by ethnicity.
There were suggestive associations at three loci in IL6 and TNFA in the comparison
between active cases and controls (Table 2), three loci in APOL1, MIF and IL6 in the
Susceptibility/Resistance candidate genes to HAT
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Table 1. Population characteristics.
Cases (n = 100) Controls (n = 100) Latent infections (n = 33) Whole population (n = 233)
Age mean 41,8 36,8 36 38,8
Males 53 42 14 109
Females 47 58 19 124
TL+ve 65 0 18 83
TL-ve 35 100 15 150
https://doi.org/10.1371/journal.pntd.0005992.t001
Fig 1. Multidimensional scaling (ms) plots of the genotype data by ethnicity (upper plot) and phenotype (lower plot). The plots show no
evidence of clustering either by ethnicity or phenotype.
https://doi.org/10.1371/journal.pntd.0005992.g001
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comparison between latent infections and active cases (Table 3) and five loci in IL4 (Fig 2),
and one each in HLA-G and TNFA between latent infections and controls (Table 4). After Bon-
ferroni correction, none of these associations remained significant, however Bonferroni cor-
rection is very conservative, particularly since there was some linkage between adjacent SNP
marker in some genes. The Benjamini-Hochberg false discovery rate (FDR) test, which shows
the probability that an observation is a false positive, indicated that at least some of the sugges-
tively positive samples may be true positives. Under the FDR the rs62449495 SNP in IL6 had
an 80% chance of being a true positive and the TNFA-308 rs1800629 SNP had a 71% chance of
being a true positive (Table 2). The strongest association was with APOL1 rs73885319, which
is also known as the G1 allele, which had a 90% chance of being a true positive in the compari-
son between latent infections and controls (Table 3). Complete results for all tests that passed
quality control are shown in supplementary data tables (S1, S2 and S3 Tables).
Discussion
In this study, we investigated the role of SNPs on susceptibility/resistance to HAT. We geno-
typed 96 SNPs within sixteen genes that were investigated to test genetic association with HAT
in Coˆte d’Ivoire. For consistency, all samples were commercially genotyped using two plat-
forms: Genome Transcriptome de Bordeaux, France and LGC Genomics UK.
Our results suggest that three SNPs were associated with the development of HAT by con-
trols, another three were associated with the development of active HAT by people with latent
infections, and seven SNP were associated with the risk of developing latent infections five of
them in IL4 although none of these results remained significant after Bonferroni correction.
Only two of the SNP with suggestive associations were coding and missense (IL6 rs2069830
and APOL1 rs73885319) since, with some exceptions, SNP were primarily selected as tags that
might be linked to functional SNP rather than for any putative function.
The most striking feature of the results is that most associations were found in the compari-
sons with latent infections, despite limited power, with only 33 of these samples being available
compared with 100 each for the cases and controls. This illustrates the increased power to be
gained from using well defined phenotypes. Given the evidence that some people in West
Africa can self-cure their T. b. gambiense infections [5] it is likely that some of the control sub-
jects are resistant to infection or have recovered from infection, whilst others are naïve and
susceptible. These two groups may have very different genetic backgrounds which could con-
found the association studies. The data also suggest that the latent infections may represent a
genetically distinctive group. Although the principle component analysis did not identify any
Table 2. Association tests between cases (n = 99) and controls (n = 100).
CHR BP SNP Gene Cons Min A Cases Controls Maj A P Bonf_Corr FDR_BH OR L95 U95 HWE_p
7 22,764,338 rs62449495 IL6 5’ A 0.04 0.13 G 0.0025 0.20 0.20 0.30 0.13 0.68 1.00
6 31,543,031 rs1800629 TNFA 5’ A 0.09 0.19 G 0.0071 0.58 0.29 0.44 0.24 0.80 0.51
7 22,767,137 rs2069830 IL6 Missense T 0.11 0.06 C 0.0369 1.00 0.81 2.17 1.02 4.61 1.00
https://doi.org/10.1371/journal.pntd.0005992.t002
Table 3. Association tests between latent infections (n = 32) and active HAT cases (n = 99).
CHR BP SNP Gene Cons Min A Cases Latent Maj A P Bonf_Corr FDR_BH OR L95 U95 HWE_p
22 36,661,906 rs73885319 APOL1 Missense G 0.20 0.41 A 0.0012 0.10 0.10 0.37 0.20 0.68 1.00
22 24,235,455 rs36086171 MIF 5 ‘ G 0.29 0.13 A 0.0062 0.52 0.26 2.90 1.30 6.46 0.05
7 22,764,338 rs62449495 IL6 5’ A 0.04 0.13 G 0.0217 1.00 0.61 0.29 0.10 0.80 1.00
https://doi.org/10.1371/journal.pntd.0005992.t003
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cluster associated with latent infections (Fig 1) further studies of their genetic and immunolog-
ical profiles are required to test this hypothesis.
Associations with IL6
The minor (A) allele of IL6 rs62449495 appeared to protect against progression from latent
infections to active HAT (Table 3) and against the development of active HAT by controls but
these associations did not remain significant after Bonferroni correction (Table 2). The major
allele of rs2069830 was also protective against the development of active HAT by controls
before but not after Bonferroni correction (Table 2). The rs2069830 SNP causes a proline to
serine change, but this is predicted to be benign by both Sift and Polyphen according to the
Ensembl Variant Effect predictor. IL6 plays a key role in the acute inflammatory response and
in regulation of the production of acute phase proteins such as C-reactive protein [22]. It con-
tributes to the inflammatory response, regulates haematopoiesis, which may contribute to the
anaemia associated with HAT, and modifies the permeability of the blood brain barrier, which
may contribute to the development of the stage 2 invasion of the CNS [22,23]. The results of
our association study are consistent with the involvement of IL6 variants in the susceptibility
to the disease as Courtin et al [15] have reported before. However, it should be noted that the
polymorphisms of IL6 in our study (rs62449495 and rs2069830) are different of those found by
Courtin et al. [15] with IL64339 = rs2069849. They showed that in DRC, IL64339 SNP was signif-
icantly associated with a decreased risk of developing the disease with a P-value = 0.0006
before the Bonferroni correction (0.04 after Bonferroni Correction).
Fig 2. Positions of SNP genotyped within IL4. SNP with suggestive associations (uncorrected p <0.05) are indicated with a star.
https://doi.org/10.1371/journal.pntd.0005992.g002
Table 4. Association tests between latent infections (n = 32) and controls (n = 100).
CHR BP SNP Gene Cons Min A Latent Controls Maj A P Bonf_Corr FDR_BH OR L95 U95 HWE_p
5 132,009,154 rs2243250 IL4 5’ C 0.42 0.27 T 0.0159 1.00 0.48 2.02 1.13 3.64 0.80
5 132,010,726 rs734244 IL4 Intronic T 0.25 0.41 C 0.0215 1.00 0.48 0.49 0.26 0.92 0.01
5 132,016,554 rs2243282 IL4 Intronic A 0.30 0.45 C 0.0347 1.00 0.48 0.53 0.29 0.96 1.00
6 29,799,116 rs1611139 HLAG 3’ T 0.26 0.14 G 0.0354 1.00 0.48 2.13 1.04 4.36 0.39
5 132,009,710 rs2070874 IL4 5’ UTR T 0.34 0.50 C 0.0372 1.00 0.48 0.53 0.30 0.96 0.69
6 31,543,031 rs1800629 TNFA 5’ A 0.08 0.19 G 0.0396 1.00 0.48 0.37 0.14 0.99 0.51
5 132,014,109 rs2243270 IL4 Intronic A 0.36 0.23 G 0.0415 1.00 0.48 1.88 1.02 3.45 1.00
Cons = Consequence from Ensembl Variant predictor, Min A = minor allele, Maj A = major allele, Latent minor allele frequency of Latent cases; Controls
minor allele frequency of controls; OR = odds ratio, P = p-value, [L95-U95] = confidence interval of odds ratio, Bonf_Corr = Bonferroni corrected p value,
FDR_BH = False Discovery Rate Benjamini-Hochberg (It is probability of falsely rejecting the null hypothesis. The null hypothesis is that allele frequencies
in cases and controls are the same), OR = odds ratio, [L95-U95] = confidence interval; HWE P is the Hardy-Weinberg p-value.
https://doi.org/10.1371/journal.pntd.0005992.t004
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Association with TNFA
Our results also indicate that subjects carrying the A allele of TNFA (rs1800629) A/G had a
lower risk of developing active HAT (Table 2) or a latent infection (Table 4), suggesting the
possibility of a protective effect. This SNP is also known as the TNF-308 SNP and the minor A
allele is associated with higher plasma levels of TNFA [24]. In a previous study in Coˆte d’Ivoire,
Courtin et al. [11] showed that the distribution of the TNFA-308G/A polymorphism did not dif-
fer significantly between cases and controls in the total population, but found that, under a reces-
sive model the AA genotype was associated with risk of HAT in the 39 cases and 57 controls
who had been living in the endemic area of Sinfra for less than 10 years (before Bonferroni cor-
rection). In contrast, in our study, all participants had lived in the endemic area all their lives and
the association was additive rather than recessive, furthermore the MAF in Courtin’s studies was
24%, whilst in ours it was 14%, suggesting significant differences in population structure between
the two studies. Varying results in TNFA associations studies are not uncommon, multiple can-
didate gene association studies of TNFA-308 (rs1800629) and malaria have found inconsistent
results in different populations [25,26]. Another explanation could be that the TNFA-308 has no
effect but is in linkage disequilibrium (LD) with another unidentified polymorphism. Varying
LD across populations might lead to different findings [27]. Despite the conflicting results from
association study, animal models indicate that TNFA is likely to be a key mediator in the control
of T. brucei infections [28] and a direct dose dependent lytic effect of TNFA on purified T.b. gam-
biense parasites has been reported suggesting an involvement in parasite growth control [29,30].
Given the experimental evidence for a role for TNFA, it is possible that inconsistent results of
association studies are a consequence of different TNFA alleles only making a small difference to
infection outcome and that therefore larger studies would be needed to detect associations and
also to heterogeneity in regulation of TNFA between populations.
Association with IL4
Five of the seven SNP that were suggestively associated with the comparison between latent
infections and controls were in IL4 (Table 4, Fig 2). Three of these SNP were adjacent to each
other at the 5’ end of the gene (Fig 2), although linkage between them was modest (r2 <0.5).
While the individual associations did not remain significant after Bonferroni correction the
observation that five of the sixteen SNP tested in IL4 had suggestive associations increases the
probability of a genuine association with IL4 and the risk of developing a latent infection. A
study using three IL4 SNP in DRC did not find any associations, but that was in a comparison
between cases and controls [15]. In B10.Q mice deletion in IL4 lead to increased T. brucei para-
sitaemia levels but longer survival time [18]. The relationship between IL4 polymorphisms and
acute HAT infection requires further study.
Association with APOL1
The suggestive association with APOL1 G1 allele rs73885319 and protection against progres-
sion from latent infection to active HAT is consistent with the association found in Guinea
[31,32], although in those studies this SNP was also associated with increased risk of controls
developing a latent infection as well. Moreover, APOL1 expression is induced by T. b. gam-
biense infection but not associated with differential susceptibility to sleeping sickness [21].
APOL1 rs73885319 is also known as the G1 allele of APOL1 and is associated with kidney dis-
ease in African Americans and the relatively high frequency of this deleterious allele was
assumed to be due to selection by HAT [33]. The data presented here is consistent with that
hypothesis, but no support was found for the role of the G2 allele of APOL1 (rs71785313) in
HAT although it is implicated in kidney disease.
Susceptibility/Resistance candidate genes to HAT
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Association with MIF
Although, our data show that subjects carrying the G allele of MIF (rs36086171) G/A had a
risk of developing active HAT (Table 3), we did not find a significant difference after correc-
tion (BONF = 0.52). MIF is a ubiquitously expressed protein that has proinflammatory, hor-
monal and enzymatic activities [34]. It is implicated in many inflammatory diseases [35]. It
functions by recruiting myeloid cells to the site of inflammation [36], by inducing their differ-
entiation towards M1 cells secreting TNF [37] and by suppressing p53-dependent apoptosis of
inflammatory cells. While there are no human studies directly linking MIF to HAT, murine
studies show that MIF plays a role as a mediator of the inflammation which is a key feature in
trypanosomiasis-associated pathology [16,38].
Association with HLA-G
HLA-G molecule plays an important role on immune response regulation and has been associ-
ated with the risk of human immunodeficiency virus (HIV) infection [39], human papilloma
virus [40] and herpes simplex virus type 1 [41]. The results of our association study are consis-
tent with the involvement of HLA-G genetic variants in the susceptibility to the disease [12].
Control subjects with rs1611139 T allele of the HLA-G gene showed a suggestive association
with increased risk of leading in latent infection in case they are infected. This result could be
due to differences in selection pressures possibly driven by variability in the immuno-pathol-
ogy of the diseases. It is known that cytokines such as IL-10 can induce HLA-G expression by
affecting mRNA transcripts and protein synthesis by human monocytes and trophoblasts, thus
having a significant impact on parasitic infections [42].
Conclusion
The results discussed in this paper should be used with caution as no loci remained signifi-
cantly associated with HAT after the Bonferroni correction for multiple testing, although some
had high probabilities of being associated using a FDR test. Some of the SNP loci identified
here were also significant in other studies. Multiple independent observations of marginally
significant effects suggest that these effects may be genuine but that the effect size is not large
enough to be detected by the numbers available to be tested.
Our data support the findings from Guinea about the role of the APOL1 G1 allele and also
suggest that the polymorphisms of IL4, IL6, HLA-G and TNFA present interesting candidates
for the investigation of the genetic susceptibility / resistance to HAT.
The large number of suggestive associations with latent infections despite the small number
of samples indicate the people with latent infections form a genetically distinctive group that
merit further investigation.
Materials and methods
Population study, definition of phenotypes and study design
The study took place in western-central Coˆte d’Ivoire in the main HAT foci of Bonon, Bouafle,
Zoukougbeu, Oume, and Sinfra. Samples were collected in three stages: (i) previously archived
samples; existing collections of previously archived samples were centralized to Centre Inter-
national de Recherche-De´veloppement sur l’Elevage en zone Subhumide (CIRDES) in Bur-
kina-Faso, (ii) retrospectively collected samples for which study sites were revisited for consent
and resample previously diagnosed and treated patients and (iii) prospectively collected sam-
ples including new HAT cases. Three phenotypes were considered: (i) cases, defined as indi-
viduals in whom the presence of trypanosomes was confirmed by microscopy and trypanolysis
Susceptibility/Resistance candidate genes to HAT
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test positive (TL+ve) but trypanolysis negative (TL-ve) for some cases who were retrospectively
sampled for the purpose of this study and who had not been subject to the trypanolysis test
(TL) when originally identified as HAT cases by microscopy; (ii) controls, defined as individu-
als living in the endemic area who are card agglutination test for trypanosomiasis (CATT) neg-
ative (CATT-ve) and trypanolysis test negative (TL-ve), and without evidence of previous
HAT infection and (iii) latent infections, defined as subjects who were CATT positive (CATT
+ve) with plasma dilution higher or equal to ¼ (CATTpl1/4) but in whom parasites could
not be detected by microscopy at repeated tests for at least two years.
A total of 233 individuals with 100 HAT cases, 100 controls and 33 latent infections were
included in the study. Samples were frozen directly in the field at -20˚C and kept at that tem-
perature until use. For each individual, an aliquot of plasma was used to perform the immune
TL test that detects Litat 1.3 and Litat 1.5 variable surface antigens specific for T.b. gambiense
[43].
This study was one of five populations studies of HAT endemic areas in Cameroon, Coˆte
d’Ivoire, Guinea, Malawi and Uganda by the TrypanoGEN consortium [44]. The studies were
designed to have 80% power to detect odds ratios (OR) >2 for loci with disease allele frequen-
cies of 0.15–0.65 and 100 cases and 100 controls with the 96 SNPs genotyped. Power calcula-
tions were undertaken using the genetics analysis package gap in R [45].
Selection of SNPs and genotyping
Genomic DNA was obtained from peripheral blood samples. Extraction was performed using
the Qiagen DNA extraction kit (QIAamp DNA Blood Midi Kit) according to the manufactur-
er’s instructions and quantified by Nanodrop assay. DNA was stored at -20˚C until analysis.
Ninety-six SNPs were genotyped in IL1, IL4, IL4R, IL6, IL8, IL10, IL12, IL12R, TNFA, INFG,
MIF, HPR, CFH, APOL1, HLA-A, and HLA-G. The SNPs were selected by two strategies: 1) SNP
in IL4, IL6, IL8, HLAG and IFNG were designed as markers for linkage disequilibrium (LD)
scans of each gene [46], 2) SNPs in other genes were selected based on reports in the literature
that they were associated with trypanosomiasis or other infectious diseases. The LD scans were
designed using 1000 Genomes Project data [47], merged with low fold coverage (8-10x) whole
genome shotgun data generated from 230 residents living in regions (DRC, Guinea Conakry,
Coˆte d’Ivoire and Uganda) where trypanosomiasis is endemic (TrypanoGEN consortium, Euro-
pean Nucleotide Archive study EGAS00001002482). Loci with minor allele frequency< 5% in
the reference data were excluded and an r2 of 0.5 was used to select SNP in LD.
DNA was genotyped by two commercial service providers: INRA- Site de Pierroton, Plate-
forme Genome Transcriptome de Bordeaux, France and ii- LGC genomics Hoddesden UK. At
INRA multiplex design (two sets of 40 SNPs) was performed using Assay Design Suite v2.0
(Agena Biosciences). SNP genotyping was achieved with the iPLEX Gold genotyping kit
(Agena Biosciences) for the Mass Array iPLEX genotyping assay, following the manufacturer’s
instructions. Products were detected on a Mass Array mass spectrophotometer and data were
acquired in real time with Mass Array RT software (Agena Biosciences). SNP clustering and
validation was carried out with Typer 4.0 software (Agena Biosciences). At LGC Genomics
SNP were genotyped using the PCR based KASP assay[48].
Statistical analysis
All statistical analyses were performed using the Plink 1.9 and R v 3.2.1 software. Individuals
were excluded who had> 10% missing SNP data. SNP loci were excluded that > 10% missing
genotypes or if the control samples were not in Hardy-Weinberg equilibrium (p<0.001).
Case-control association analysis using SNP alleles/genotypes was undertaken using Fisher’s
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exact test. The difference between the ethnic groups was estimated using the FST, with values
potentially varying from zero (no population differentiation) to one (complete differentiation)
[47]. Ethnicity was not used as a risk factor for HAT because we observed no significant differ-
ences in FST between ethnic groups (FST maximum 0.015) or clustering by linguistic group by
multidimensional scaling in Plink. Some studies have used ethnicity and age as risk factors for
HAT but found no significant association [11,15]. 77 SNP remained in at least one comparison
after filtering. P values were adjusted for multiple testing using the Bonferroni corrections and
Benjamini Hocheberg false discovery rate test as implemented in Plink.
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